The Mitral Valve Stenosis Market is anticipated to reach USD 4.3 Billion by 2032 at 7.7% CAGR during the forecast period 2023-2032. Mitral valve stenosis (MVS) presents a complex interplay of medical needs, technological advancements, and market dynamics. As a condition characterized by the narrowing of the mitral valve opening, MVS poses significant challenges to patients and healthcare...